– Completes IPO, Expands Patent Portfolio, and Strengthens Board Independence – TUCSON, Ariz., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced financial results for the three and nine months ended September 30, 2025. Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, Inc., comment ...

INSPIRE MEDICAL SYSTEMS INVESTORS: Inspire Medical Systems, Inc. (INSP) has been Sued for Securities Fraud, Investors are Urged to Contact BFA LawNovember 14, 2025 6:09 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud afte ...

BOULDER, CO / ACCESS Newswire / November 14, 2025 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2026 second quarter that ended September 30, 2025. The Company posted quarterly product net revenue of $1.48 million and service net revenue of $46 thousand, or total net revenue of $1.52 million, resulting in a quarterly n ...

Heidelberg, Germany, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Heidelberg, Germany — November 14, 2025 — Heidelberg Engineering today announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. The step reflects a long-term commitment to advance patient-centric innovation through multi-stakeholder collaboration, rigorous science, and global consensus-building. C ...

Milestone Scientific Inc. (NYSE:MLSS) shares surged 35.67% in after-hours trading on Thursday, rising to $0.52. The medical device firm reported its third-quarter results showing lower costs and improved losses.Check out the current price of MLSS stock here.The stock closed 6.03% higher at $0.38 on Thursday, according to Benzinga Pro data.Cost Reduction Drives Improved MarginsThe New Jersey-based biomedical technology firm reduced its operating expenses by more than $500,000 in the third quarter compared wi ...

市场环境与基金表现 - 第三季度美国股市持续上涨，罗素中型股增长指数上涨2.78% [3] - 美联储降息及稳健的经济数据对股市形成支撑 [3] - Wasatch美国精选基金（投资者类别）同期表现落后，下跌1.93% [3] 基金表现不佳的原因 - 基金持仓集中，少数股票下跌对整体业绩产生较大影响 [4] - 部分公司报告收入增长放缓，股价大幅下跌，投资者在争论放缓原因是宏观经济环境还是竞争压力 [4] - 市场风格不利于基金策略，低质量公司股票受到青睐，这对专注于高质量、长期增长公司的投资流程构成直接逆风 [7] 拖累业绩的主要持股分析 - BellRing Brands是季度内最大的拖累因素，其一家俱乐部渠道合作伙伴扩大了蛋白奶昔品类货架空间并引入其他竞争对手，但管理层仍对公司保持信心，认为其有将业务翻倍的空间 [8] - Shift4 Payments拖累业绩，尽管其最近季度有机收入以高十位数百分比增长，但股价因市场对疲软宏观经济影响的担忧以及收购Global Blue导致投资者情绪转差而下跌 [9] - Inspire Medical Systems拖累业绩，因管理层下调2025年全年指引且新一代产品商业推广延迟，基金已在季度内出售该头寸 [10] 贡献业绩的主要持股分析 - Medpace Holdings是最大贡献者，这家合同研究组织报告了强劲的收入和盈利增长，并上调了全年指引，其在生物技术融资周期放缓背景下的表现令人印象深刻 [11] - Fabrinet是主要贡献者，公司为数据中心等设计制造光电产品，其产品采用率强劲，但基金并非将其作为人工智能主题投资进行持有 [12] - Nova Ltd.同样贡献业绩，公司销售用于半导体制造的计量和过程控制系统，其产品需求旺盛，与人工智能主题的关联可能助推了股价 [13] 投资策略与展望 - 尽管对季度业绩失望，但基金不会偏离其投资流程，将继续坚持寻找高质量、长期增长公司的纪律 [14] - 基金持仓公司的基本面依然令人鼓舞，多数公司盈利增长强劲，这使其对基金未来三至五年的回报潜力感到兴奋 [15]

开展首日，新品科技的脉动扑面而来，现场人头攒动、互动热烈。科技魅力正通过一系列硬核产品与沉浸体验，吸引一批又一批专业观众驻足交 流。 （原标题：21现场｜从"跑步参会"到"全球首发" 高交会跻身科技首秀场） 21世纪经济报道记者 吴佳楠 深圳报道 走过27个年头的高交会，已然成为科技产品的首秀舞台。 11月14日，第二十七届中国国际高新技术成果交易会（简称"高交会"）在深圳开幕。近5000家企业参展，首发首秀和路演推介活动超过60场次， 首发、首展展品占比达20%以上。 作为全球"科技风向标"的高交会，成为世界顶尖科技产品在中国乃至全球的首秀舞台。深圳这座被誉为中国"硅谷"、南方科技中心的创新之城， 也正向着全球科技新品首发中心的华丽蜕变进发。 全球科技产品选择在此首发，正是看中深圳能将技术瞬间转化为产品和市场的魔力。 从现场首发、首展的新品、爆款看，这里每一款亮相的科技产品都精准触达产业链关键环节，迅速引发科技行业共振。 高科技产品集中首发首展 今年提出"阿尔法战略"的荣耀首次将"AI终端生态"搬进高交会展区，AI宠物生态正是其中之一。 "这是荣耀首次将AI宠物生态解决方案带到高交会展区。主要是通过AI的视 ...

21世纪经济报道记者 吴佳楠 深圳报道 走过27个年头的高交会，已然成为科技产品的首秀舞台。 11月14日，第二十七届中国国际高新技术成果交易会（简称"高交会"）在深圳开幕。近5000家企业参 展，首发首秀和路演推介活动超过60场次，首发、首展展品占比达20%以上。 作为全球"科技风向标"的高交会，成为世界顶尖科技产品在中国乃至全球的首秀舞台。深圳这座被誉为 中国"硅谷"、南方科技中心的创新之城，也正向着全球科技新品首发中心的华丽蜕变进发。 全球科技产品选择在此首发，正是看中深圳能将技术瞬间转化为产品和市场的魔力。 从现场首发、首展的新品、爆款看，这里每一款亮相的科技产品都精准触达产业链关键环节，迅速引发 科技行业共振。 高科技产品集中首发首展 华力创科学也在现场首度公开世界首创的灵巧手严肃触觉感知解决方案，发布灵巧手多维触感指节 Photon Finger tip产品，该新品通过多款微型多维力传感器，并搭载在灵巧手上，能赋予灵巧手接近人类 的指尖触觉，可实现与复杂表面信息的感知合力。 "目前公司的产品不仅应用在人形机器人产品上，也同步应用在包括医疗、工业等场景。"华力创科学 CEO鱼晨博士向记者表示，力传感 ...

New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the "Class Period") of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

ROSEN, A RANKED AND LEADING FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAXNovember 13, 2025 7:51 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), o ...